Tevogen Bio Holdings Stock Buy Hold or Sell Recommendation
| TVGN Stock | 1.37 0.03 2.24% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Tevogen Bio Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of Tevogen Bio's available fundamental, technical, and predictive indicators you will find on this site.
Check out Tevogen Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Tevogen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Tevogen Bio Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Tevogen |
Execute Tevogen Bio Buy or Sell Advice
The Tevogen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Tevogen Bio Holdings. Macroaxis does not own or have any residual interests in Tevogen Bio Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Tevogen Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Tevogen Bio Trading Alerts and Improvement Suggestions
| Tevogen Bio Holdings is way too risky over 90 days horizon | |
| Tevogen Bio Holdings may become a speculative penny stock | |
| Tevogen Bio Holdings appears to be risky and price may revert if volatility continues | |
| Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGST. | |
| Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tevogen Bio generates negative cash flow from operations | |
| Tevogen Bio Holdings has a frail financial position based on the latest SEC disclosures | |
| About 97.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Tevogen Bio Prepares Organizational Readiness to Support Companys Growth Strategy |
Tevogen Bio Returns Distribution Density
The distribution of Tevogen Bio's historical returns is an attempt to chart the uncertainty of Tevogen Bio's future price movements. The chart of the probability distribution of Tevogen Bio daily returns describes the distribution of returns around its average expected value. We use Tevogen Bio Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Tevogen Bio returns is essential to provide solid investment advice for Tevogen Bio.
| Mean Return | 3.48 | Value At Risk | -17.3 | Potential Upside | 32.69 | Standard Deviation | 26.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Tevogen Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Tevogen Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Tevogen Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Tevogen Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Tevogen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 3.85 | |
β | Beta against Dow Jones | -3.19 | |
σ | Overall volatility | 27.38 | |
Ir | Information ratio | 0.12 |
Tevogen Bio Volatility Alert
Tevogen Bio Holdings is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Tevogen Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Tevogen Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Tevogen Bio Fundamentals Vs Peers
Comparing Tevogen Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Tevogen Bio's direct or indirect competition across all of the common fundamentals between Tevogen Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Tevogen Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Tevogen Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Tevogen Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Tevogen Bio to competition |
| Fundamentals | Tevogen Bio | Peer Average |
| Return On Asset | -0.83 | -0.14 |
| Current Valuation | 258.98 M | 16.62 B |
| Shares Outstanding | 164.61 M | 571.82 M |
| Shares Owned By Insiders | 96.61 % | 10.09 % |
| Shares Owned By Institutions | 4.58 % | 39.21 % |
| Number Of Shares Shorted | 3.69 M | 4.71 M |
| EBITDA | 188.71 K | 3.9 B |
| Net Income | (67.33 K) | 570.98 M |
| Total Debt | 1.63 M | 5.32 B |
| Cash Flow From Operations | (1.38 M) | 971.22 M |
| Short Ratio | 0.07 X | 4.00 X |
| Beta | 0.48 | -0.15 |
| Market Capitalization | 164.61 M | 19.03 B |
| Total Asset | 17.04 M | 29.47 B |
| Retained Earnings | (17.38 M) | 9.33 B |
| Working Capital | (2.65 M) | 1.48 B |
| Net Asset | 17.04 M |
Note: Acquisition by Saadi Ryan H. of 2607 shares of Tevogen Bio at 0.7671 subject to Rule 16b-3 [view details]
Tevogen Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Tevogen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Tevogen Bio Buy or Sell Advice
When is the right time to buy or sell Tevogen Bio Holdings? Buying financial instruments such as Tevogen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Tevogen Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Providers Thematic Idea Now
Insurance Providers
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Tevogen Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (0.83) |
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.